Posted: Sunday, April 25, 2021. 8:33 am CST.
By Zoila Palma: The European Medicines Agency (EMA) said that a new review of the AstraZeneca COVID-19 vaccines indicated that its benefits increase with age and still outweigh risks despite recent links to blood clots.
The EMA issued a statement saying that its findings shows that the benefits of the vaccine increase with older people and infection rates.
“The benefits of Vaxzevria outweigh its risks in adults of all age groups; however, very rare cases of blood clots with low blood platelets have occurred following vaccination,” the statement said.
In addition, the agency said that the rare blood clots occurred in 1 in 100,000 people who received the vaccine.
“The most common side effects are usually mild or moderate and get better within a few days,” the agency added.
In early April, the same agency said that a rare but fatal form of blood clot affecting the brain should be listed as a side effect.
Channel News Asia reports that so far, 287 cases worldwide are linked to AstraZeneca, 25 to the Pfizer-BioNTech vaccine, eight to the Johnson and Johnson shot and five to the Moderna jab.
Advertise with the mоѕt vіѕіtеd nеwѕ ѕіtе іn Belize ~ We offer fully customizable and flexible digital marketing packages. Your content is delivered instantly to thousands of users in Belize and abroad! Contact us at mаrkеtіng@brеаkіngbеlіzеnеwѕ.соm or call us at 501-601-0315.
© 2021, BreakingBelizeNews.com. Content is copyrighted and requires written permission for reprinting in online or print media. Theft of content without permission/payment is punishable by law.